DK0488470T3 - Fremgangsmåde til fremstilling af antistoffer - Google Patents

Fremgangsmåde til fremstilling af antistoffer

Info

Publication number
DK0488470T3
DK0488470T3 DK91203080.6T DK91203080T DK0488470T3 DK 0488470 T3 DK0488470 T3 DK 0488470T3 DK 91203080 T DK91203080 T DK 91203080T DK 0488470 T3 DK0488470 T3 DK 0488470T3
Authority
DK
Denmark
Prior art keywords
lymphocytes
producing antibodies
antibodies
immortalized
preceded
Prior art date
Application number
DK91203080.6T
Other languages
Danish (da)
English (en)
Inventor
Petrus Gerardus A Steenbakkers
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0488470T3 publication Critical patent/DK0488470T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK91203080.6T 1990-11-26 1991-11-25 Fremgangsmåde til fremstilling af antistoffer DK0488470T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90203124 1990-11-26

Publications (1)

Publication Number Publication Date
DK0488470T3 true DK0488470T3 (da) 1997-12-22

Family

ID=8205174

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91203080.6T DK0488470T3 (da) 1990-11-26 1991-11-25 Fremgangsmåde til fremstilling af antistoffer

Country Status (12)

Country Link
EP (1) EP0488470B1 (de)
JP (1) JP3392883B2 (de)
KR (1) KR100223381B1 (de)
AT (1) ATE153695T1 (de)
AU (1) AU646108B2 (de)
CA (1) CA2056102C (de)
DE (1) DE69126281T2 (de)
DK (1) DK0488470T3 (de)
ES (1) ES2103770T3 (de)
GR (1) GR3024487T3 (de)
NZ (1) NZ240748A (de)
ZA (1) ZA919299B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474755A (en) * 1984-01-31 1995-12-12 Akzo Nobel N.V. Tumor associated monoclonal antibodies
EP0650735A3 (de) * 1993-07-09 1999-04-14 Akzo Nobel N.V. Kit und Verfahren zum Vorziehen
AU698184B2 (en) * 1994-02-04 1998-10-29 Akzo Nobel N.V. Monoclonal antibody 88BV59, subclones and method of making
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them
ZA9710391B (en) * 1996-12-06 1998-06-23 Akzo Nobel Nv Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent.
US7037663B2 (en) 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
AU763247C (en) 1998-02-19 2005-05-19 Eastern Virginia Medical School Recombinant active human zona pellucida protein 3 (hZP3)
US6541225B1 (en) * 2000-01-26 2003-04-01 Raven Biotechnologies, Inc. Methods and compositions for generating human monoclonal antibodies
SE0002835D0 (sv) * 2000-08-07 2000-08-07 Karolinska Innovations Ab Method and kit for production of monoclonal antibodies
EP1319184B1 (de) 2000-08-14 2007-07-25 N.V. Organon Verwendung von antikörpern gegen spezifische mhc-peptidkomplexe
WO2003011118A2 (en) 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
WO2004087911A1 (ja) * 2003-03-28 2004-10-14 Toyama New Industry Organization １個の抗原特異的ｂリンパ球を用いた抗原特異的抗体産生ハイブリドーマの作製方法及びモノクローナル抗体の製造方法
GB0312481D0 (en) * 2003-05-30 2003-07-09 Celltech R&D Ltd Antibodies
EP1658498A1 (de) * 2003-08-20 2006-05-24 Celltech R & D Limited Verfahren zur gewinnung von antikörpern
US7807415B2 (en) 2005-08-23 2010-10-05 Iq Therapeutics Bv Methods of producing stable B-lymphocytes
MX2008014692A (es) * 2006-05-19 2009-08-18 Alder Biopharmaceuticals Inc Metodo de cultivo para obtener una poblacion clonal de celulas b especificas de antigeno.
US9056905B2 (en) 2007-05-21 2015-06-16 Alderbio Holdings Llc Antibodies to TNF-α and use thereof
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US7906117B2 (en) 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
SG183742A1 (en) 2007-05-21 2012-09-27 Alderbio Holdings Llc Antibodies to il-6 and use thereof
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
MX2012005927A (es) 2009-11-24 2012-11-23 Alder Biopharmaceuticals Inc Anticuerpos para il-6 uso de los mismos.
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
WO2012071561A2 (en) 2010-11-23 2012-05-31 Alder Biopharmaceuticals, Inc. Anti-il-6 antibodies for the treatment of anemia
EP3363813A1 (de) 2011-06-23 2018-08-22 Ablynx NV Verfahren für vorhersage, nachweis und verringerung von aspezifischer proteininterferenz bei tests mit variablen immunglobulin-einzeldomänen
MX350074B (es) 2011-06-23 2017-08-25 Ablynx Nv Tecnicas para predecir, detectar, y reducir la interferencia de proteinas no especificas en ensayos que implican dominios variables individuales de inmunoglobulina.
EP4350345A3 (de) 2011-06-23 2024-07-24 Ablynx N.V. Verfahren zur vorhersage, erkennung und reduzierung von aspezifischer proteininterferenz in tests mit variablen immunglobulin-einzeldomänen
EP2727942A1 (de) 2012-11-05 2014-05-07 MAB Discovery GmbH Bispezifische Antikörper gegen menschliche EGFR, HER2 und HER3
EP2914629A1 (de) 2012-11-05 2015-09-09 MAB Discovery GmbH Verfahren zur herstellung multispezifischer antikörper
EP2727941A1 (de) 2012-11-05 2014-05-07 MAB Discovery GmbH Verfahren zur Herstellung multispezifischer Antikörper
EP2727943A1 (de) 2012-11-05 2014-05-07 MAB Discovery GmbH Trispezifische Antikörper gegen menschliche EGFR, HER2 und HER3
AU2014232225B2 (en) * 2013-03-15 2020-03-19 H. Lundbeck A/S. Protocol for identifying and isolating antigen-specific B cells and producing antibodies to desired antigens
EP3313887A2 (de) 2015-06-26 2018-05-02 MAB Discovery GmbH Monoklonale anti-il1racp-antikörper
PL3436571T3 (pl) * 2016-03-30 2023-09-25 F. Hoffmann-La Roche Ag Sposób hodowli limfocytów B
EP3241845A1 (de) 2016-05-06 2017-11-08 MAB Discovery GmbH Humanisierte anti-il-1r3-antikörper
EP3562936B1 (de) 2017-01-02 2024-05-22 F. Hoffmann-La Roche AG Verfahren zur kultivierung von b-zellen
EP3401332A1 (de) 2017-05-08 2018-11-14 MAB Discovery GmbH Anti-il-1r3 antikörper zur verwendung bei entzündungskrankheiten
WO2018210896A1 (en) 2017-05-19 2018-11-22 F. Hoffmann-La Roche Ag Method for the production of thymocyte supernatant
WO2019105864A1 (en) 2017-11-30 2019-06-06 F. Hoffmann-La Roche Ag B-cell cultivation method
US12054552B2 (en) 2022-09-21 2024-08-06 Sanofi Biotechnology Humanized anti-IL-1R3 antibody and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131878A3 (de) * 1983-07-19 1987-08-05 Sloan-Kettering Institute For Cancer Research Verfahren zur Herstellung menschlicher monoklonaler Antikörper
US4797473A (en) * 1986-06-25 1989-01-10 Regents Of The University Of Minnesota Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
DE4107765A1 (de) * 1990-07-28 1992-01-30 Schebo Tech Medizinisch Biolog Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt

Also Published As

Publication number Publication date
CA2056102A1 (en) 1992-05-27
NZ240748A (en) 1996-12-20
ZA919299B (en) 1992-08-26
KR100223381B1 (ko) 1999-10-15
DE69126281D1 (de) 1997-07-03
JPH0576383A (ja) 1993-03-30
DE69126281T2 (de) 1997-10-16
GR3024487T3 (en) 1997-11-28
CA2056102C (en) 2003-03-25
JP3392883B2 (ja) 2003-03-31
ES2103770T3 (es) 1997-10-01
AU8817391A (en) 1992-08-20
ATE153695T1 (de) 1997-06-15
EP0488470A1 (de) 1992-06-03
KR920009987A (ko) 1992-06-26
EP0488470B1 (de) 1997-05-28
AU646108B2 (en) 1994-02-10

Similar Documents

Publication Publication Date Title
DK0488470T3 (da) Fremgangsmåde til fremstilling af antistoffer
DK0906426T3 (da) Antistoffer mod ED-B-domænet af fibronektin, deres konstruktion og anvendelser
DE122004000017I1 (de) Monoklonaler Antik¦rper gegen ein Cytotoxin, denselben erzeugendes Hybridoma und Verfahren f}r die Herstellung des gereinigten Cytotoxin.
ES2103751T3 (es) Procedimiento para la obtencion de oxetanonas.
DK0380068T3 (da) Ekspressionssystem til fremstilling af kimære monoklonale antistoffer
DK0538754T3 (da) Anvendelse af antistofholdige præparater til immunundertrykkelse
BG40318A3 (en) Method for preparing imunoglobuline derivatives of vindezine
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DK0840620T3 (da) IL-8-antagonister til behandling af astma
ES2114547T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c.
ES2115022T3 (es) Inmunoensayo de isotiazolonas.
AU623753B2 (en) Anti-human sperm antibody, and its production
NO962125D0 (no) Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor
ATE173504T1 (de) Granulozytenbindende antikörperkonstrukte, ihre herstellung und verwendung
DK0459450T3 (da) Monoklonalt antistof, som genkender membran-phospholipase A2 og immunobestemmelse af membran-phospho liphase A2
ATE132906T1 (de) Neuartige antiidiotypische monoklonale antikörper
DK0491240T3 (da) Fremgangsmåde til fremstilling af vandopløselige sulfonerede diphosphaner
ES2059726T3 (es) Anticuerpos monoclonales que reconocen el itsp humano, hibridomas que producen los mismos, y su preparacion y uso.
EA200200730A1 (ru) Способ идентификации веществ, имитирующих эпитопы млекопитающих
TW245721B (en) Monoclonal antibody specific to organophosphate pesticide monocrotophos
IT1267669B1 (it) Metodo per la produzione di anticorpi monoclonali specifici per le chemochine
KR960023044A (ko) 재조합 인간 에리스로포이에틴에 대한 단일클론항체 및 이를 생산하는 신규의 융합세포주
DK557287D0 (da) Murin hybridoma lym-2, dermed fremstillet monoklonalt antistof og fremangsmaade til fremstilling af antistoffet